Procedimientol to detect medical conditions relevant to a sample of solubilized lbc.

A method for assessing diagnosis of a tumor selected from the group consisting of tumors of the anogenital tract, tumors of the gastrointestinal tract, respiratory tract tumors and tumors of the urinary system from solubilized samples Cytology liquid (CBC) consisting of steps of a. detecting the presence or absence and / or level of a polypeptide marker selected from the group of p16INK4a, claudin, Ki67, KiS1, PCNA MCM-2, MCM-5, CDC-6, Her-2 / Neu, Cyclin E and a polypeptide HPV derived from a HPV gene selected from the group consisting of HPV L1, HPV L2, HPV El, HPV E2, HPV E4, HPV E5, HPV E6 and HPV E7; b. comparing the presence or absence and / or level of said marker polypeptide to the presence or absence and / or the level known as characteristic of a non-pathological healthy body sample; and c. assessing diagnosis of the tumor based on the presence or absence and / or level of said marker polypeptide in the cells contained in the LBC sample compared to a non-pathological healthy body sample.